175 related articles for article (PubMed ID: 953987)
1. Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A.
Fidler IJ; Darnell JH; Budmen MB
Cancer Res; 1976 Oct; 36(10):3608-15. PubMed ID: 953987
[TBL] [Abstract][Full Text] [Related]
2. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
3. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
Sone S; Poste G; Fidler IJ
J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
[TBL] [Abstract][Full Text] [Related]
4. In vitro activation of mouse macrophages by rat lymphocyte mediators.
Fidler IJ; Darnell JH; Budmen MB
J Immunol; 1976 Aug; 117(2):666-73. PubMed ID: 950467
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
Sone S; Fidler IJ
J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
[TBL] [Abstract][Full Text] [Related]
6. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
Ogura T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
[TBL] [Abstract][Full Text] [Related]
7. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
Poste G; Kirsh R
Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
Fidler IJ; Bucana C
Cancer Res; 1977 Nov; 37(11):3945-56. PubMed ID: 908034
[TBL] [Abstract][Full Text] [Related]
9. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
10. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
[TBL] [Abstract][Full Text] [Related]
11. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
12. Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants.
Fidler IJ
J Natl Cancer Inst; 1975 Nov; 55(5):1159-63. PubMed ID: 1206741
[TBL] [Abstract][Full Text] [Related]
13. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
Fidler IJ; Schroit AJ
J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
[TBL] [Abstract][Full Text] [Related]
14. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
15. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
Fogler WE; Fidler IJ
Cancer Res; 1985 Jan; 45(1):14-8. PubMed ID: 3855280
[TBL] [Abstract][Full Text] [Related]
16. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
17. Enhanced in vitro macrophage cytotoxicity against interferon-treated B16 melanoma cells.
Fleischmann CM; Fleischmann WR
J Biol Regul Homeost Agents; 1995; 9(4):139-45. PubMed ID: 8844338
[TBL] [Abstract][Full Text] [Related]
18. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
Schultz RM; Chirigos MA
Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
[TBL] [Abstract][Full Text] [Related]
19. In vitro induction of cytotoxic polymorphonuclear leukocytes by supernatant from a concanavalin A-stimulated spleen cell culture.
Inoue T; Sendo F
J Immunol; 1983 Nov; 131(5):2508-14. PubMed ID: 6605388
[TBL] [Abstract][Full Text] [Related]
20. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
